Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Borrello

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Blood|October 31, 2002
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimerasLeo Luznik, Jill E Slansky, Sanju Jalla, et al.
Cancer Research|March 9, 2005
Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursorsKimberly Noonan, William Matsui, Paolo Serafini, et al.
International Journal of Hematology|July 4, 2012
Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myelomaAsher A Chanan-Khan, Sagar Lonial, Donna Weber, et al.
Nature Reviews. Clinical Oncology|March 31, 2011
The bone marrow stroma in hematological neoplasms--a guilty bystanderClaudio Tripodo, Sabina Sangaletti, Pier P Piccaluga, et al.
Molecular Cancer Therapeutics|May 9, 2014
Activation of liver X receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myelomaJasmin R Agarwal, Qiuju Wang, Toshihiko Tanno, et al.
Molecular Cancer Therapeutics|August 31, 2016
IQGAP1 Scaffold-MAP Kinase Interactions Enhance Multiple Myeloma Clonogenic Growth and Self-RenewalChristian B Gocke, Ross McMillan, Qiuju Wang, et al.
Leukemia Research|November 12, 2021
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CMLJonathan A Webster, Tara M Robinson, Amanda L Blackford, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma modelChristiane Meyer, Alexandra Sevko, Marcel Ramacher, et al.
Blood|December 19, 2013
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cellsToshihiko Tanno, Yiting Lim, Qiuju Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinomaDonald T Weed, Jennifer L Vella, Isildinha M Reis, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Blood|October 31, 2002
Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimerasLeo Luznik, Jill E Slansky, Sanju Jalla, et al.
Cancer Research|March 9, 2005
Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursorsKimberly Noonan, William Matsui, Paolo Serafini, et al.
International Journal of Hematology|July 4, 2012
Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myelomaAsher A Chanan-Khan, Sagar Lonial, Donna Weber, et al.
Nature Reviews. Clinical Oncology|March 31, 2011
The bone marrow stroma in hematological neoplasms--a guilty bystanderClaudio Tripodo, Sabina Sangaletti, Pier P Piccaluga, et al.
Molecular Cancer Therapeutics|May 9, 2014
Activation of liver X receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myelomaJasmin R Agarwal, Qiuju Wang, Toshihiko Tanno, et al.
Molecular Cancer Therapeutics|August 31, 2016
IQGAP1 Scaffold-MAP Kinase Interactions Enhance Multiple Myeloma Clonogenic Growth and Self-RenewalChristian B Gocke, Ross McMillan, Qiuju Wang, et al.
Leukemia Research|November 12, 2021
A randomized, phase II trial of adjuvant immunotherapy with durable TKI-free survival in patients with chronic phase CMLJonathan A Webster, Tara M Robinson, Amanda L Blackford, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma modelChristiane Meyer, Alexandra Sevko, Marcel Ramacher, et al.
Blood|December 19, 2013
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cellsToshihiko Tanno, Yiting Lim, Qiuju Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinomaDonald T Weed, Jennifer L Vella, Isildinha M Reis, et al.
Pageof 9